How are we doing? Quality in Breast Cancer Care Dr Michelle Goecke Surgical Oncology Network Update October 18, 2014.

Slides:



Advertisements
Similar presentations
Yasir Rudha, MD; Amr Aref, MD; Paul Chuba, MD; Kevin O’Brien, MD
Advertisements

Baptist Health System General Surgery Residency Program
Breast Cancer. Introduction Most common female cancer Accounts for 32% of all female cancer 211,300 new cases yearly and rising 40,000 deaths yearly.
AJCC TNM Staging 7th Edition Thyroid Case #3
Histopathology and Cytology for Breast lesions Britt-Marie Ljung MD Professor of Pathology, Dir. of Cytology University of California at San Francisco.
DCIS – Are we cutting it? Dr Alex Lemaigre With thanks to:
Breast Cancer in Pregnancy
Christine Simmons, MD MSc FRCPC Medical Oncologist, BCCA Vancouver
SCREENING MAMMOGRAPHY PROGRAM Screening Mammography in 2014: Still Controversial? Dr. Christine Wilson MEDICAL DIRECTOR, SCREENING MAMMOGRAPHY.
Sentinel Lymph Node Biopsy in Melanoma
Julie R. Gralow, M.D. Director, Breast Medical Oncology, Seattle Cancer Care Alliance Professor, Medical Oncology, University of Washington School of Medicine.
First HAYAT Annual Patients Forum – 21 st March 2010 – SAS, Kuwait First HAYAT Annual Patients Forum 21 st March 2010 Al Hashimi II Ballroom – SAS Hotel.
Role of MRI in Breast Cancer Angela Kong Princess Margaret Hospital.
Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery
Clinical Utility of Combidex in Various Cancers
AJCC TNM Staging 7th Edition Breast Case #3
Faculty of Medicine - Benha University
Margins: less is just as good
Meta-analysis of trials of radiotherapy in DCIS Early Breast Cancer Trialists’ Collaborative Group (EBCTCG)
West Midlands Cancer Intelligence Unit NHSBSP Surgical QA Data for the Year of Screening 1 April 2002 to 31 March 2003 Dr Gill Lawrence and Professor Jan.
Ductal Carcinoma in situ
Intra-Operative Radiation Therapy for Treatment of Early Stage Breast Cancer: Short Term Results from a Single Institution Clinical Trial Using Electronic.
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #2 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
Elshami M.Elamin, MD Medical Oncologist Central Care Cancer Center Wichita, KS, USA
Maximally-Invasive Curriculum: A Model Curriculum for Osteopathic Surgical Residencies (ACOS) India Broyles, EdD University of New England College of Osteopathic.
Racial/Ethnic Disparities in Cancer Incidence, Survival and Treatment Linda C. Harlan, PhD, MPH National Cancer Institute Division of Cancer Control and.
Eleni Galani Medical Oncologist
The influence of Breast Cancer Pay for Performance Initiatives on breast cancer survival and performance measures: a pilot study in Taiwan Raymond NC Kuo,
Piya Kiatisevi 1, Torsten Nielsen 2, Malcolm Hayes 2, Peter L Munk 3, Amy E LaFrance 4, Paul W Clarkson 4, Bassam A Masri 4 1 Orthopaedic Oncology Lerdsin.
The Value of Six Month Interval Imaging Following Benign Radiologic-Pathologic Concordant Minimally Invasive Breast Biopsy Manjoros DT, Collett AE, Alberty-Oller.
Clare Rogers Consultant Breast Surgeon Doncaster and Bassetlaw Hospitals.
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
EVALUATION OF LYMPH NODES & PATHOLOGIC EXAMINATION FOR BREAST CASES Tonya Brandenburg, MHA, CTR Kentucky Cancer Registry.
The Breast Clinic Index case Year 2 Michaelmas term.
Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2013 – December 31, 2013 Compiled by Uzma Nazim, M.D.
Changes in Breast Cancer Reports After Second Opinion Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain.
Katie Ludwig FY1.   50, 285 New cases of breast cancer  11, 716 deaths  78% - 10 year survival rates  27% preventable cases  Source:
Quality in Cancer Surgery Dr. Craig McFadyen VP Cancer Services, Grand River Hospital Regional VP (Waterloo-Wellington), Cancer Care Ontario Medical Director.
How are Auckland Surgeons Managing the Axilla? E Whineray Kelly, O Pellet, L Neave, J Harman, R Harman. Auckland Breast Cancer Study Group.
Challenges of Cancer Diagnosis in Resource Limited Settings Optimizing Pathology Support Ann Marie Nelson, M.D. AIDS and Infectious Disease Pathology Joint.
Ductal Carcinoma in Situ with Microinvasion: Prognostic Implications, Long-term Outcomes, and Role of Axillary Evaluation Rahul R. Parikh, MD 1, Bruce.
MBCG Project Primary Results MEDICALSURVEYS-17 RESEARCH GROUP IN COLLABORATION WITH THE EASO.
Cancer Outcomes and Services Dataset Linda Wintersgill Information & Audit Manager, NECN.
Clinical Correlations The NYU Internal Medicine Blog A Daily Dose of Medicine
Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2014 – December 31, 2014 Compiled by L.Day, RN BSN CCM CCRP OCN 1.
Radiotherapy Protocols Bristol protocol version 12.
Quality Assurance Report TTUHSC Breast Center of Excellence January 1, 2010 – December 31, 2010 Compiled by Lynn Day, RN BSN CCM CCRP.
1 OncoCollect ™ Collection of Real World Data in Oncology Dr Ramesh B V Nimmagadda Director, Medical Oncology Apollo Speciality Cancer hospital, Chennai.
Cancer Committee Meeting May 11, 2015 Cancer Liaison Physician Report Karen Lisa Smith MD MPH.
From Qualitative to Quality Impact Heather Bryant, MD, PhD Health System Use Summit February, 2016.
Annals of Oncology 24: 2206–2223, 2013 R3 조영학
Linking Electronic Health Records Across Institutions to Understand Why Women Seek Care at Multiple Sites for Breast Cancer Caroline A. Thompson, PhD,
Assessing Quality of Pathology Reporting: The Case of Tongue Cancer Lihua Liu 1, PhD Wesley Y. Naritoku 2, MD, PhD Juanjuan Zhang 1, MS Lenard Berglund.
M.J. Diaz-Ruiz 1 ; A. Soldevila 1, A. Arnau 2 ; R. Monmany 1 ; O. Valencoso 1 ; D. Coll 1 ; A. Miguel 3, T. Montes 4, V. Villa 5. 1 Radiology Service.
[Name of Presenter] [Details of patient e.g. initials, hospital number etc.] [Date of meeting]
Figure 1: a 32-year-old woman presented with RT breast mass, MRI showed false positive diagnosis of cancer. Dynamic contrast enhanced MRI, axial subtraction.
Overview: Breast Cancer- Surgical Treatment
Ultrasound breast core needle biopsy
Indications for Breast MR Imaging
USING NATIONAL GUIDELINES FOR SCREENING, TREATMENT, AND FOLLOW-UP
Update of the management of
Erica V. Bloomquist, MD Heather Wright, MD
But how to treat those with positive SLNB? Results and Discussion
SPECIMEN SONOGRAM - Procedure
معيارهاي ارزشيابي برنامه ثبت سرطان دانشگاهي ارسال به موقع اطلاعات (هر سه ماه)(2) گردآوري از لحاظ پيدا كردن موارد جديد سرطاني از منابع ذيل: - ثبت.
Neoadjuvant Therapy in HER2-Positive Breast Cancer
Treatment Overview: The Multidisciplinary Team
‘Improving Outcomes for people with skin tumours, including Melanoma’
Cancer 101: A Cancer Education and Training Program for [Target Population] Date Location Presented by: Presenter 1 Presenter 2 1.
Assessment of Breast and Colorectal Cancer Surgery in Manitoba
Presentation transcript:

How are we doing? Quality in Breast Cancer Care Dr Michelle Goecke Surgical Oncology Network Update October 18, 2014

Disclosure Relationships with commercial interests: None

Quality of Care “ the degree to which health services for individuals and populations increase the likelihood of desired health outcomes and are consistent with current professional knowledge” Institute of Medicine, 1990

Quality Indicators Based on standards of care Relevant, measurable and within the control of those delivering the care Different types – Performance/processes of care – Outcome

Quality Indicators in Breast Cancer Care Diagnosis Surgery Local regional treatment Systemic treatment Staging Counselling, Follow-up and Rehabilitation

Quality Indicators in Breast Cancer Care Indicator Level of Evidence Mandatory/ Recommended Minimum Standard Target

Quality Indicators in Breast Cancer Care

Breast Cancer Care in British Columbia

SON Breast Tumour Group Quality Measures Core biopsy diagnosis Orientation of surgical specimen Radiologic confirmation of fine wire specimens Sentinel lymph node biopsy in early stage breast cancer Margin details noted in operative report Clips in cavity after breast-conserving surgery

Breast Cancer Care in British Columbia SON Breast Tumour Group Quality Measures – BCCA Breast Cancer Registry – Breast Cancer Outcomes Unit (BCOU) Fraser Health Clinical Audit Mt. St. Joseph’s Rapid Access Breast Clinic Audit

Breast Cancer in BC in new diagnoses Mean age 61 86% referred to the cancer agency – 88% Invasive carcinoma – 90% Early Stage

Breast Cancer in BC in % 29% 48%44% Surgical Management

QI: Preoperative Definitive Diagnosis Patients with breast cancer should have a non- operative histological diagnosis Rationale – Reduces number of unnecessary operations – Plan treatment – Patient counselling Target 90%

QI: Preoperative Definitive Diagnosis The utilization and impact of core needle biopsy diagnosis on breast cancer outcomes in British Columbia BCMJ, Vol. 56, No. 4, May 2014, page(s) Kristy Cho, Scott Tyldesley, MD, FRCPC, Caroline Speers, BA, Barbara Poole Lane, MPA, Karen A. Gelmon, MD, FRCPC, Christine Wilson, MD, FRCPC Study results indicate that open surgical procedures are being overused for the diagnosis of breast cancer in BC’s more sparsely populated regions.

QI: Preoperative Definitive Diagnosis Preoperative core biopsy diagnosis (534) 96% Surgical biopsy diagnosis (23) 4% MSJ Rapid Access Breast Clinic 2012

QI: Preoperative Definitive Diagnosis FHA Clinical Audit 2012

QI: Radiologic Confirmation of Fine Wire Specimen Rationale – Most DCIS and 60% Stage 1 cancers are imaged detected requiring image localization – Need to document successful target excision Used for pathologic and radiologic correlation

QI: Radiologic Confirmation of Fine Wire Specimen FWL ProcedureN (%) Image done, lesion seen1075 (80) Image done, lesion not seen21 (2) No image done46 (4) Unknown if image done/lesion seen189 (14) BCOU Data 2011 Target: 100%

QI: Orientation of Surgical Specimen To determine the location of the margin pathologic status Margin status strongly correlates with local recurrence rate Allows for targeted re-excision Target: 100%

QI: Orientation of Surgical Specimen Oriented Specimen BCOU % FHA % (3 of 9 sites 100%)

QI: Surgical Approach to the Axilla Patients with invasive breast cancer and clinically node negative should have a sentinel lymph node biopsy Rationale – LN status is important for prognosis and treatment planning – SLNBx is the accepted means of staging in clinically node negative patients Target: 95%

QI: Surgical Approach to the Axilla SLNBX in Early Stage Breast Cancer BCCA/BCOU % FHA % MSJ % Target: 90-95%

Summary QIs exist for all aspects of breast cancer care Data on QIs is difficult to collect and extract There is room for improvement in British Columbia Synoptic reporting can improve data collection